Dr. Akil H Hutchinson, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-6414 |
Loba B Alam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 |
Dr. Sahar Ilyas, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-6414 |
Gowri Chandra, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 |
Viswanath Malladi, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 Fax: 973-290-8325 |
Mounir R. Ibrahim, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-6414 Fax: 908-598-2337 |
Sarah Shihadeh, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-6414 Fax: 908-598-2337 |
Dr. Alex Maharaj, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 |
News Archive
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009.
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific survival, overall survival and disease-free survival, while pretreatment SUVmax for lymphodenopathy is strongly associated with distant metastasis, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.
LDR, a total spine solution company, announced today the expansion of its lumbar VerteBRIDGE product offering following 2 years of successful clinical use of the ROI-A® ALIF Cage. The new applications offer a complete range of alternatives to currently adopted lateral approaches. The new direct lateral and oblique lumbar systems have been used successfully in Europe in more than 100 cases.
Many recent reports have found multidrug resistant bacteria living in hospital sink drainpipes, putting them in close proximity to vulnerable patients.
Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems - led by cancer-fighting Natural Killer cells - stutter and fail in the presence of excess fat.
› Verified 4 days ago